Simultaneous Pharmacologic Inhibition of Yes-Associated Protein 1 and Glutaminase 1 via Inhaled Poly(Lactic-co-Glycolic) Acid-Encapsulated Microparticles Improves Pulmonary Hypertension.

MLA

Acharya, Abhinav P., et al. “Simultaneous Pharmacologic Inhibition of Yes-Associated Protein 1 and Glutaminase 1 via Inhaled Poly(Lactic-Co-Glycolic) Acid-Encapsulated Microparticles Improves Pulmonary Hypertension.” Journal of the American Heart Association, vol. 10, no. 12, June 2021, p. e019091. EBSCOhost, https://doi.org/10.1161/JAHA.120.019091.

APA

Acharya, A. P., Tang, Y., Bertero, T., Tai, Y.-Y., Harvey, L. D., Woodcock, C.-S. C., Sun, W., Pineda, R., Mitash, N., Königshoff, M., Little, S. R., & Chan, S. Y. (2021). Simultaneous Pharmacologic Inhibition of Yes-Associated Protein 1 and Glutaminase 1 via Inhaled Poly(Lactic-co-Glycolic) Acid-Encapsulated Microparticles Improves Pulmonary Hypertension. Journal of the American Heart Association, 10(12), e019091. https://doi.org/10.1161/JAHA.120.019091

Chicago

Acharya, Abhinav P, Ying Tang, Thomas Bertero, Yi-Yin Tai, Lloyd D Harvey, Chen-Shan C Woodcock, Wei Sun, et al. 2021. “Simultaneous Pharmacologic Inhibition of Yes-Associated Protein 1 and Glutaminase 1 via Inhaled Poly(Lactic-Co-Glycolic) Acid-Encapsulated Microparticles Improves Pulmonary Hypertension.” Journal of the American Heart Association 10 (12): e019091. doi:10.1161/JAHA.120.019091.